Christel Renoux,  MD, PhD Assistant Professor, Dept. of Neurology & Neurosurgery McGill University Centre For Clinical Epidemiology Jewish General Hospital - Lady Davis Research Institute Montreal Canada

Testosterone Replacement Therapy Linked to Increased Risk of Heart Attack and Stroke

MedicalResearch.com Interview with:

Christel Renoux,  MD, PhD Assistant Professor, Dept. of Neurology & Neurosurgery McGill University Centre For Clinical Epidemiology Jewish General Hospital - Lady Davis Research Institute Montreal Canada

Dr. Renoux

Christel Renoux,  MD, PhD
Assistant Professor, Dept. of Neurology & Neurosurgery
McGill University
Centre For Clinical Epidemiology
Jewish General Hospital – Lady Davis Research Institute
Montreal Canada

MedicalResearch.com: What is the background for this study?

Response: Testosterone replacement therapy is increasingly being prescribed for the treatment of non-specific symptoms among aging men. However, there are concerns regarding the cardiovascular safety of testosterone replacement therapy in aging men and warnings have been issued by health agencies.

MedicalResearch.com: What are the main findings?

Response: In this population-based cohort study of men aged 45 years or older with low testosterone levels, we found that use of testosterone replacement therapy was associated with an increased risk of ischemic stroke, transient ischemic attack and myocardial infarction compared with non-use. The risk was highest in the first two years of use and decreased thereafter. 

MedicalResearch.com: What should readers take away from your report?

Response: Based on the results of our study and from prior studies, the potential harms of testosterone replacement therapy should be weighed against its expected benefits when considering this treatment in aging men.

MedicalResearch.com: What recommendations do you have for future research as a result of this work?

Response: Further large observational studies should be conducted to reaffirm these results and to further delineate the risk in patients with different baseline cardiovascular risk.

No disclosures

Citation:

Simone Y. Loo, Laurent Azoulay, Rui Nie, Sophie Dell’Aniello, Oriana Hoi Yun Yu, Christel Renoux. Cardiovascular and Cerebrovascular Safety of Testosterone Replacement Therapy Among Aging Men with Low Testosterone Levels: A Cohort Study. The American Journal of Medicine, 2019; DOI: 10.1016/j.amjmed.2019.03.022

[wysija_form id=”3″]

Jul 22, 2019 @ 9:20 pm

The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.

 

No Comments

Post A Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.